Dr. Bremner – Finding New Ways to Treat Retinitis Pigmentosa
Scientific Title: A platform to identify new drug targets for retinitis pigmentosa
Lead Investigator: Dr. Rod Bremner
Institution: Lunenfeld-Tanenbaum Research Institute, Sinai Health System
Granted: $300,000 over 2 years
People living with retinitis pigmentosa experience gradual vision loss which is caused by the death of light sensing cells in the retina, called photoreceptors. In this project, Dr. Bremner and his team will use a high throughput technology to identify proteins that are causing the cell to die. They will then test drugs to stop this from happening.
Join the Fight!
Learn how your support is helping to bring a future without blindness into focus! Be the first to learn about the latest breakthroughs in vision research and events in your community by subscribing to our e-newsletter that lands in inboxes the beginning of each month.